JPMORGAN CHASE & CO - CTI BIOPHARMA CORP ownership

CTI BIOPHARMA CORP's ticker is CTIC and the CUSIP is 12648L601. A total of 41 filers reported holding CTI BIOPHARMA CORP in Q4 2019. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
JPMORGAN CHASE & CO ownership history of CTI BIOPHARMA CORP
ValueSharesWeighting
Q1 2023$4,724,000
+66173.8%
1,124,714
-5.2%
0.00%0.0%
Q4 2022$7,128
-99.9%
1,186,030
+4.1%
0.00%0.0%
Q3 2022$6,630,000
-5.2%
1,139,110
-2.8%
0.00%0.0%
Q2 2022$6,996,000
+38766.7%
1,171,774
+30162.8%
0.00%
Q1 2022$18,000
-14.3%
3,872
-53.4%
0.00%
Q4 2021$21,0000.0%8,303
+14.0%
0.00%
Q3 2021$21,000
-12.5%
7,283
-23.7%
0.00%
Q2 2021$24,000
+9.1%
9,539
+25.5%
0.00%
Q1 2021$22,000
-18.5%
7,601
-10.6%
0.00%
Q4 2020$27,000
+200.0%
8,500
-0.4%
0.00%
Q3 2020$9,000
-10.0%
8,538
-0.0%
0.00%
Q2 2020$10,000
+25.0%
8,539
+0.5%
0.00%
Q1 2020$8,000
-96.9%
8,500
-94.7%
0.00%
Q4 2019$255,000
+4.9%
161,661
-44.5%
0.00%
Q3 2019$243,000
-23.6%
291,481
-22.0%
0.00%
Q2 2019$318,000
-18.9%
373,867
-7.6%
0.00%
Q1 2019$392,000
+26.5%
404,477
-4.0%
0.00%
Q4 2018$310,000
-74.8%
421,492
-25.9%
0.00%
Q3 2018$1,229,000
-27.1%
568,732
+68.1%
0.00%
Q2 2018$1,685,000
+61.4%
338,346
+26.4%
0.00%
Q1 2018$1,044,000
+260.0%
267,752
+147.2%
0.00%
Q4 2017$290,000
+6.6%
108,313
+26.8%
0.00%
Q3 2017$272,000
+750.0%
85,448
+1015.2%
0.00%
Q1 2017$32,0007,6620.00%
Other shareholders
CTI BIOPHARMA CORP shareholders Q4 2019
NameSharesValueWeighting ↓
Stonepine Capital Management, LLC 3,904,400$3,355,0002.31%
BVF INC/IL 6,929,690$5,955,0000.65%
CAXTON CORP 324,452$279,0000.32%
NEA Management Company, LLC 3,750,000$3,222,0000.23%
Orbimed Advisors 5,000,000$4,297,0000.07%
Fosun International Ltd 459,274$390,0000.03%
Paloma Partners Management Co 229,800$197,0000.00%
LMR Partners LLP 54,931$47,0000.00%
OXFORD ASSET MANAGEMENT LLP 127,602$110,0000.00%
MILLENNIUM MANAGEMENT LLC 689,551$593,0000.00%
View complete list of CTI BIOPHARMA CORP shareholders